share_log

东瑞制药(02348.HK)拟3月22日举行董事会会议批准全年业绩

Dongrui Pharmaceuticals (02348.HK) plans to hold a board meeting on March 22 to approve annual results

Gelonghui Finance ·  Mar 8 04:28

Gelonghui, March 8, 丨 Dongrui Pharmaceutical (02348.HK) issued an announcement. The company's board of directors meeting will be held on March 22, 2024 (Friday) to approve (among other things) the publication of the annual results announcements of the company and its subsidiaries for the year ended December 31, 2023, and to consider the proposed payment of a final dividend (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment